Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
8,600
Employees8,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
8,600
Employees8,600

ILMN Key Statistics

Market cap
29.01B
Market cap29.01B
Price-Earnings ratio
35.27
Price-Earnings ratio35.27
Dividend yield
Dividend yield
Average volume
2.29M
Average volume2.29M
High today
$196.66
High today$196.66
Low today
$189.09
Low today$189.09
Open price
$194.00
Open price$194.00
Volume
2.58M
Volume2.58M
52 Week high
$196.66
52 Week high$196.66
52 Week low
$88.00
52 Week low$88.00

Stock Snapshot

Illumina(ILMN) stock is priced at $191.82, giving the company a market capitalization of 29.01B. It carries a P/E multiple of 35.27.

During the trading session on 2026-07-08, Illumina(ILMN) shares reached a daily high of $196.66 and a low of $189.09. At a current price of $191.82, the stock is +1.4% higher than the low and still -2.5% under the high.

Trading activity shows a volume of 2.58M, compared to an average daily volume of 2.29M.

Over the past 52 weeks, Illumina(ILMN) stock has traded between a high of $196.66 and a low of $88.00.

Over the past 52 weeks, Illumina(ILMN) stock has traded between a high of $196.66 and a low of $88.00.

ILMN News

MarketWatch 9h
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

...

Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TipRanks 2d
Illumina price target raised to $200 from $155 at Evercore ISI

Evercore ISI raised the firm’s price target on Illumina (ILMN) to $200 from $155 and keeps an Outperform rating on the shares. The firm’s Q2 preview for MedTech...

Simply Wall St 2d
Is Illumina Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly’s R&D Chief on Board?

Illumina, Inc. recently expanded its Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., an independent director and Eli Lilly’s Chi...

Is Illumina Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly’s R&D Chief on Board?

Analyst ratings

52%

of 23 ratings
Buy
52.2%
Hold
26.1%
Sell
21.7%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.